Treatment of neuromyelitis optica: Review and recommendations

Treatment of neuromyelitis optica: Review and recommendations

Εμφάνιση άλλων εκδόσεων (1)

Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and immunopathogenesis that does not respond to tr...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Kimbrough, D, Fujihara, K, Jacob, A, Lana-Peixoto, M, Isabel Leite, M, Levy, M, Marignier, R, Nakashima, I, Palace, J, De Seze, J, Stuve, O, Tenembaum, SN, Traboulsee, A, Waubant, E, Weinshenker, BG, Wingerchuk, D, Guthy Jackson Charitable Foundation Clinical Consortium and Biorepository
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	Elsevier 2012

Παρόμοια τεκμήρια

Treatment of Neuromyelitis Optica: Review and Recommendations.
ανά: Kimbrough, D, κ.ά.
Έκδοση: (2012)

Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide
ανά: Jyh Yung Hor, κ.ά.
Έκδοση: (2020-06-01)

Eculizumab in aquaporin-4-positive neuromyelitis optica spectrum disorder.
ανά: Pittock, S, κ.ά.
Έκδοση: (2019)

Neuroimmunology: towards more-accurate diagnosis in neuromyelitis optica.
ανά: Fujihara, K, κ.ά.
Έκδοση: (2014)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
ανά: Collongues, N, κ.ά.
Έκδοση: (2013)

The borderland of neuromyelitis optica.
ανά: Matthews, L, κ.ά.
Έκδοση: (2009)

Neuromyelitis optica associated with systemic autoimmune diseases in children
ανά: Russo RA, κ.ά.
Έκδοση: (2008-09-01)

Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy.
ανά: Mealy, M, κ.ά.
Έκδοση: (2014)

Seronegative Neuromyelitis Optica Spectrum - The challenges on disease definition and pathogenesis
ανά: Douglas Kazutoshi Sato, κ.ά.
Έκδοση: (2014-06-01)

Atypical presentations of neuromyelitis optica
ανά: Douglas Sato, κ.ά.
Έκδοση: (2011-10-01)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
ανά: Kim, W, κ.ά.
Έκδοση: (2012)

Use of mitoxantrone in neuromyelitis optica.
ανά: Kitley, J, κ.ά.
Έκδοση: (2011)

Current and future treatment approaches for neuromyelitis optica
ανά: Nicolas Collongues, κ.ά.
Έκδοση: (2011-03-01)

Treatment of neuromyelitis optica: an evidence based review
ανά: Douglas Sato, κ.ά.
Έκδοση: (2012-01-01)

Differential diagnosis of neuromyelitis optica spectrum disorders
ανά: Sung-Min Kim, κ.ά.
Έκδοση: (2017-07-01)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
ανά: Nour, M, κ.ά.
Έκδοση: (2014)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
ανά: Elsone, L, κ.ά.
Έκδοση: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
ανά: Waters, P, κ.ά.
Έκδοση: (2015)

Magnetic resonance imaging in neuromyelitis optica.
ανά: Tackley, G, κ.ά.
Έκδοση: (2014)

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica
ανά: Nicolas Collongues, κ.ά.
Έκδοση: (2016-05-01)

Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort
ανά: Shervin Gholizadeh, κ.ά.
Έκδοση: (2024-10-01)

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
ανά: Cree, BAC, κ.ά.
Έκδοση: (2019)

A practical guide to the treatment of neuromyelitis optica.
ανά: Palace, J, κ.ά.
Έκδοση: (2012)

The evolving clinical spectrum of neuromyelitis optica
ανά: Viegas, S, κ.ά.
Έκδοση: (2008)

A mathematical model of cellular swelling in Neuromyelitis optica
ανά: Laranjeira, S, κ.ά.
Έκδοση: (2017)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
ανά: Sato, D, κ.ά.
Έκδοση: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
ανά: Matthews, L, κ.ά.
Έκδοση: (2014)

The role of imaging in diagnosing neuromyelitis optica spectrum disorder
ανά: Matthews, L, κ.ά.
Έκδοση: (2013)

Neuromyelitis Optica
ανά: Goyal V, κ.ά.
Έκδοση: (2009-10-01)

Neuromyelitis optica
ανά: Jacob Anu, κ.ά.
Έκδοση: (2007-01-01)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
ανά: Nour, M, κ.ά.
Έκδοση: (2015)

Imaging Surrogates of Disease Activity in Neuromyelitis Optica Allow Distinction from Multiple Sclerosis.
ανά: Lucy Matthews, κ.ά.
Έκδοση: (2015-01-01)

Anti-aquaporin-4 antibodies in Devic’s neuromyelitis optica: therapeutic implications
ανά: Romain Marignier, κ.ά.
Έκδοση: (2010-09-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
ανά: Viegas, S, κ.ά.
Έκδοση: (2009)

Seasonal pattern of variation in neuromyelitis optica relapses
ανά: Elsone, L, κ.ά.
Έκδοση: (2012)

NMO-IgG in the diagnosis of neuromyelitis optica.
ανά: Jarius, S, κ.ά.
Έκδοση: (2007)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
ανά: Luppe, S, κ.ά.
Έκδοση: (2012)

Case Report: In Situ Expression of a Proliferation-Inducing Ligand in Neuromyelitis Optica
ανά: Laurie Baert, κ.ά.
Έκδοση: (2021-08-01)

A single relapse induces worsening of disability and health-related quality of life in patients with neuromyelitis optica spectrum disorder
ανά: Achim Berthele, κ.ά.
Έκδοση: (2023-04-01)

Racial differences in neuromyelitis optica spectrum disorder
ανά: Kim, S, κ.ά.
Έκδοση: (2018)